EASL Studio is a weekly digital initiative that brings together leading experts in liver disease and research. Through live broadcasts, the programme features engaging interviews, debates, and roundtable discussions on multidisciplinary topics in hepatology for all those with an interest in the liver, no matter their location.
Designed to provide knowledge and expert perspectives, EASL Studio keeps the medical and scientific community informed on the latest advancements. Special live editions are hosted during EASL Congresses and Summits, delivering key messages on the latest science in clinical practice, prevention, and patient care.
All previous episodes can be accessed on-demand on EASL Campus.

Next episodes
September 2025
10 September
18:00 CEST |
Treating PBC: Alkaline Phosphatase response or improvement in liver stiffness?
Marco Carbone (Moderator), Christophe Hézode (Gilead Representative), Marwan Sleiman (Ipsen representative)
This EASL Studio is supported by Ipsen and Gilead Sciences Europe Ltd. |
17 September
18:00 CEST |
What Matters Most? The questions every hepatologist should ask their patients
Pierre-Emmanuel Rautou (Moderator), Agnès Dumas (Faculty), Maria Hjorth (Faculty), José Willemse (Faculty), Zobair Younossi (Faculty) |
24 September
18:00 CEST |
Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?
Ahmed Elsharkawy (Moderator), Ashley Brown (Faculty), Tatyana Kushner (Faculty), Sabela Lens (Faculty) |
October 2025
1 October
18:00 CEST |
The Clinical Blind Spot: Are We Neglecting Alcohol?
Maja Thiele (Moderator), Brian Lee (Faculty), Mzamo Mbelle (Faculty), Elisa Pose (Faculty) |
8 October
18:00 CEST |
Does it really matter whether we call it ACLF or acute decompensation?
Tom Marjot (Moderator), Paolo Angeli (Faculty), Julia Wendon (Faculty) |